Overview: NGS Epilepsy Panel Sequencing TestIntroduction: The NGS Epilepsy Panel Sequencing Test sequences epilepsy-related genes to diagnose epilepsy, causing seizures. Following 2023 AAN guidelines, it uses PCR for high specificity, supporting neurological screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for patients with suspected epilepsy.
Other Names: Epilepsy NGS Assay, Epilepsy Gene Panel.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Epilepsy sequencing began in the 2000s with seizure disorder research. NGS methods improved in the 2010s, enhancing diagnostic precision.
Purpose: Sequences epilepsy-related genes to diagnose epilepsy, guides treatment, and evaluates patients with seizures.
Test Parameters: 1. Epilepsy Genes
Pretest Condition: No fasting required. Collect whole blood, buccal swab, or saliva. Report history of seizures, aura, or epilepsy symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document seizures, aura, loss of consciousness, or family history of epilepsy. Include current medications, especially anticonvulsants.
Consent: Written consent required, detailing the tests purpose, epilepsy implications, and risks of sample collection.
Procedural Considerations: Uses next-generation sequencing to analyze epilepsy genes (e.g., SCN1A, KCNQ2). Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for epilepsy diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or improper sample storage can affect results. Contamination may reduce specificity.
Clinical Significance: Identified mutations confirm epilepsy, guiding anticonvulsant therapy or genetic counseling. Negative results may require EEG monitoring.
Specialist Consultation: Consult a neurologist for result interpretation and treatment planning.
Additional Supporting Tests: EEG, brain MRI, or video-EEG monitoring to confirm epilepsy diagnosis.
Test Limitations: Not all epilepsy cases are genetic; clinical correlation is needed. Sample quality affects sensitivity.
References: AAN Epilepsy Guidelines, 2023; Neurology, Helbig I, 2022.
